Filtered By:
Condition: Atrial Fibrillation
Countries: USA Health

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 257 results found since Jan 2013.

Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature
J Natl Med Assoc. 2023 Mar 5:S0027-9684(23)00034-2. doi: 10.1016/j.jnma.2023.02.008. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most prevalent arrhythmia in the United States and is responsible for 1 in 7 ischemic strokes. While anticoagulation is effective at preventing strokes, prior work has highlighted significant disparities in anticoagulation prescribing. Furthermore, racial, ethnic, sex, and socioeconomic disparities in AF outcomes have been described. As such, we aimed to review recent data on disparities with respect to anticoagulation for AF published between January 2018 and February 2021. The...
Source: Journal of the National Medical Association - March 7, 2023 Category: General Medicine Authors: Danielle J Daly Utibe R Essien Marcela G Del Carmen Benjamin Scirica Adam N Berman Jennifer Searl Como Jason H Wasfy Source Type: research

Biden ’ s Physical Says He ’ s ‘ Healthy ’ and ‘ Vigorous, ’ But ‘ Gait Remains Stiff ’
President Biden, who turned 80 in November, was examined by doctors at Walter Reed National Medical Center in Maryland on Thursday. It was his first check up in over a year. Biden, the oldest President in US history, is widely expected to announce in the coming months that he is running for re-election. What were the results? His physician gave him a clean bill of health, but noted Biden continues to have stiffness in his walk from a combination of arthritis in his back, neuropathy in his feet and the long-term effects of breaking his foot in November 2020 while playing with his former dog Major. Doctors conducted a routin...
Source: TIME: Health - February 16, 2023 Category: Consumer Health News Authors: Brian Bennett Tags: Uncategorized Joe Biden Longevity White House Source Type: news

Does bariatric surgery change the risk of acute ischemic stroke in patients with a history of transient ischemic attack? A nationwide analysis
CONCLUSIONS: After analyzing nationwide information, we conclude bariatric surgery helps decrease risk of AIS in patients with a history of TIA. However, this comparison is limited by the nature of the database; further studies are needed to better understand these results.PMID:36581552 | DOI:10.1016/j.soard.2022.11.013
Source: Surgery for Obesity and Related Diseases : official journal of the American Society for Bariatric Surgery - December 29, 2022 Category: Surgery Authors: Roberto J Valera Cristina Botero-Fonnegra Vicente J Cogollo Mauricio Sarmiento-Cobos Lisandro Montorfano Carlos Rivera Liang Hong Emanuele Lo Menzo Samuel Szomstein Raul J Rosenthal Source Type: research

Atrial fibrillation detection using insertable cardiac monitor after stroke: A real ‐world cohort study
ConclusionPatients with stroke or TIA have a higher rate of AF detection. However, this real-world study shows significantly lower AF detection rates than what has been previously reported.
Source: Journal of Cardiovascular Electrophysiology - November 15, 2022 Category: Cardiology Authors: Jean J. Noubiap, Gijo Thomas, Melissa E. Middeldorp, John L. Fitzgerald, Curtis Harper, Prashanthan Sanders Tags: ORIGINAL ARTICLE Source Type: research

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study
CONCLUSION: Among patients with AF, apixaban use was associated with lower risk for GIB and similar rates of ischemic stroke or systemic embolism, ICH, and all-cause mortality compared with dabigatran, edoxaban, and rivaroxaban. This finding was consistent for patients aged 80 years or older and those with chronic kidney disease, who are often underrepresented in clinical trials.PRIMARY FUNDING SOURCE: None.PMID:36315950 | DOI:10.7326/M22-0511
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Wallis C Y Lau Carmen Olga Torre Kenneth K C Man Henry Morgan Stewart Sarah Seager Mui Van Zandt Christian Reich Jing Li Jack Brewster Gregory Y H Lip Aroon D Hingorani Li Wei Ian C K Wong Source Type: research

Andexanet Alfa and its Clinical Application
Heart Int. 2020 Jun 19;14(1):20-23. doi: 10.17925/HI.2020.14.1.20. eCollection 2020.ABSTRACTFactor Xa (FXa) inhibitors are widely used for stroke prevention in patients with nonvalvular atrial fibrillation, and for the treatment and prevention of deep venous thrombosis and pulmonary embolism. Compared with warfarin, individual FXa inhibitors are associated with a lower risk of major bleeding. Nevertheless, bleeding remains a feared complication of any anticoagulant therapy. Despite their demonstrated safety, implementation of FXa inhibitors in clinical practice may have been limited by the lack of a specific antidote. Rece...
Source: Heart International - October 24, 2022 Category: Cardiology Authors: Fauve A Noordergraaf Marco Alings Source Type: research